TP53 and neoplasm: It is reported that lupine pentacyclic triterpenes have strong and broad-spectrum anti-tumor activity, low toxicity and selectivity to tumor cells, and their mechanism is independent of p53 pathway, so they are expected to become excellent anti-tumor lead compounds (Wang et al., 2017).